Platelet-rich plasma (PRP) therapy was first introduced in the 1970s and has been used in many medical specialties, including orthopedic surgery, plastic surgery, sports medicine, wound care, and pain management, since the 1990s. There has been a wide variety of recent literature about platelet rich plasma therapy, or PRP therapy, being used to treat several types of common sports injuries, such as skeletal fractures, torn ligaments and tendons, strained muscles, sprained knees and other joints, and other chronic tendon injuries. This relatively new treatment has been known to promote the regeneration of soft tissue and healing within the body without the risks and extended recovery time often associated with surgery.
Imani Holistic Medical Centre successfully completed it’s first international ACCMA & Ultrasound guided Pain management training course in Regenerative Medicine.
IMANI HOLISTIC MEDICAL CENTRE WAS PROUD TO BE ANNOUNCED AS A GLOBAL MED ACADEMY CENTRE OF EXCELLENCE AND REGENERATIVE MEDICINE TRAINING CENTRE.
Quality Precision Technology (QPT) has signed a contract manufacturing agreement with Global OrthoBiologic, Inc. (GOB). GOB and other medical device companies represent customers that are an essential part of the medical community vision, which is to manufacture cutting edge medical devices and technologies that will be successful by being used in innovative yet common, high volume medical applications.
Quality Precision Technologywill manufactureGOB products and technologies developed by the Joint Venture with “MBSI” and its own R&D subsidiary “Global LIFE”.
Randy Beimel (GOB President) Through our extensive travel and business relationships around the world, GOB has identified a huge demand for EU R&D and manufacturing to offerto non EU medical technology companies an opportunity to successfully introduce their products into the EU under the strict guidelines of European UnionLaw in order to successfully develop the market for their products through the GOB physician and distribution network.”
The analysts have forecast the global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020. According to the 2016 report, a key growth driver for the regenerative medicine market is the increased focus on cell therapy products. There are more than 40 approved cell therapy products in the market. Most small and large biotech companies are working on various cell types such as progenitor cells, adult and embryonic stem cells, and iPSCs. Cell therapies are our own body products (such as regenerative cells) that can turn into other types of cells within the body. For this reason, surgeons use regenerative cells to speed the healing of bodily tissues including bone, muscle, cartilage, ligament and tendon. When a patient’s own regenerative cells are used in high concentration they may help promote faster healing and better outcomes. These cells have proved their efficacy in the treatment of chronic heart failure, cancer, diabetes, bone fractures, spine fusions, soft tissue healing, and many other procedures.
Most cell-based immunotherapy trials are conducted in the US and European countries. The scope of cell therapy products is widening with around 300 companies and many institutes conducting more than 1,900 clinical trials around the world. Regulatory approval of products is likely to further boost its demand and augment market growth during the forecast period.
James Laird (QPT President) “Quality Precision Technology provides high quality machining solutions to carry out all needs in the: water distillation, hydraulics, oil, electronics, telecommunications, aerospace, and semi conductor industries. Equipped to design and produce everything from prototype components to fully assembled machines and equipment. Capable of handling small and medium batch work as well as repetitive orders to meet the exacting demands of the customer. Quality Precision Technology is excited to expand their manufacturing expertise into the cutting edge sector of medical devices for use in cell therapies. The use of cell therapies is one of the fastest growing segments in medical technologies and Quality Precision Technology, through their partnership with GOB intends to capitalize on it.”
About Quality Precision Technology
Established in 1983, Quality Precision Technology Ltd (QPT) has become a strategic supplier of PCB assembly’s and full turnkey solutions to a wide range of Blue Chip companies. Accredited with ISO 9001-2008 and currently engaged in receiving ISO 13485. Backed up by our own in house IPC Training School, we place quality of product and on time delivery as our priority goals whilst being price competitive at the same time. We work very closely with our customers at the design stage to make sure that all design for manufacture issues are addressed. Our customer base are involved in a wide range of activities such as Oil and Gas – Sub sea and Topside Equipment, Satellite Communications, Railway Communications, Diving and Sub sea Acoustics, IC Development and Laser Products.
Dubai, UAE (October 31, 2016). Global OrthoBiologic, Inc. (GOB), a leader in regenerative medicine currently doing business in more than 30 countries, announces a strategic Joint Venture with Lamar Holidays, a worldwide luxury travel and tourism company to provide Medical Tourism.
Medical tourism is defined as traveling from one location to another with a purpose to gain medical assistance. Generally, people from developing nations travel to developed countries for medical treatments that are unavailable in their own countries due to poor medical and healthcare infrastructure. However, in recent years, people residing in developed economies have also begun traveling to lesser developed countries in order to gain cost-efficient medical assistance. Medical Tourism or Medical Travel is a combination of wellness and healthcare coupled with leisure and relaxation which is aimed at rejuvenating a person mentally, physically and emotionally, drawing away from his daily routine to a relaxed environment in a nice and attractive location.
This partnership will provide patients across the globe the opportunity to be treated by members of the GOB Global Academy, a team of internationally known doctors and scientists offering cutting edge treatments providing better and faster recovery times.
Mihail Blagoev (GOB Vice President, International Business Development) “Medical tourism is seen as direct result of globalization of healthcare services. The falling cost of medical procedures in the Philippines, India, Singapore, Thailand, Mexico, Malaysia, Brazil, Turkey, Taiwan, South Korea, Poland, Costa Rica, and Dubai is encouraging people to travel to these countries for their treatment and, in turn, is propelling the global medical tourism market significantly. With rising initiatives by government, the UAE healthcare market is witnessing an astonishing growth in medical tourism in the region. The UAE government is extensively expanding and upgrading the existing infrastructure to match or exceed the quality of service offered in any country around the world.”
Dubai Health Experience (DXH) is the prestigious brand conceived by the Dubai Health Authority (DHA) to strengthen the position of Dubai on the world map of medical tourism. (http://dxh.ae/about-us/about-dxh/)
Firas Agha (CEO, Lamar Holidays) “The Joint Venture with GOB is a wonderful opportunity for Lamar to expand our business in medical tourism whether it is to bring patients to Dubai or to provide the complete package for the patients and families to any of the 30 countries in which GOB is conducting business. The medical tourism patients and their families have enough to be concerned with, the travel should be seamless.” Lamar specializes in luxury tourism where attention to every detail regardless how small is important to ensure the travel experience meets or exceeds the clients’ expectations.
Randy Beimel (GOB President) “Global Medical Tourism accounted for $17.1 Billion in 2015 and is poised to reach $52.2 Billion by 2022, $99 Billion by 2025.
The Joint Venture with Lamar Holidays gives GOB the platform to enter this industry by storm. The Global Academy is the collection of the best of the best physicians and scientists specializing in regenerative medicine from around the world treating patients in Orthopedic, Chronic Wound Care, Aesthetics, Cosmetic Gynecology, Spinal Cord Injuries and Neurological disorders including Autism and Cerebral Palsy. Every patient from around the globe deserves the opportunity to be treated by the best physicians regardless of the country they live in order to have the chance for the best outcome in every case.”
About Lamar Holidays
Lamar Holidays, with offices in Dubai UAE, Jeddah, Riyadh KSA, Kuala Lumpur Malaysia, Istanbul Turkey, London England, Los Angeles California, has a team of experienced professionals offering travel packages that can accommodate small family groups to large delegations. Lamar Holidays offers a multitude of luxury packages, airport transfers, worldwide accommodation, visa assistance, VIP meet and assist flights, limousine services and car rental.
The company’s management team is committed to being the leading global wholesale travel solutions provider.
Lamar offers the optimum travel solutions globally via their state of the art online system and support team that embodies the speed and quality of experience desired in each interaction. From exotic to professional, Lamar offers the client a unique and special experience.
About Global OrthoBiologic (GOB)
Global OrthoBiologic, based in Miami Florida, invests, identifies, develops and markets ground-breaking medical technologies related to Regenerative Medicine in the global market. Global OrthoBiologic is a privately-held medical technologies company specializing in therapies that significantly enhance the body’s natural healing ability. The company has developed extensive experience in the most advanced medical device industries. In the past several years, the emphasis has been focused exclusively on Regenerative Medicine and stem cell technologies, products, and therapies. The technologies for stem cells are cutting edge, safe, clean and do not use any additives, enzymes, or require culturing or growing of cells. Global OrthoBiologic consults with medical technology companies that are startups and/or companies looking to expand and grow their business. Global OrthoBiologic has built a comprehensive network of experts in Europe, South America, Middle East, Asia, and Australia. The company partners with recognized medical facilities worldwide for evidence-based clinical medicine. Global OrthoBiologic has additional sales offices in Sofia, Bulgaria and Dubai, UAE, as well as a distribution center in Amsterdam, Netherlands.
Lutry, Switzerland (October 10, 2016)
Global OrthoBiologic Inc. (GOB), a leader in regenerative medicine currently doing business in 30 countries, announces a strategic Joint Venture with MBSI Medical Biobank Swiss Institute Group, a leader in stem cells and regenerative medicine. This partnership will create a strong alliance between GOB and its global distribution network and its applied research centers based in Slovenia.
After the successful presentation at Arab Health in January, the Global OrthoBiologic, Inc. team was invited again to Dubai to discuss new business ventures and opportunities. Randy Beimel, President of GOB and Mihail Blagoev, VP International Business Development were warmly welcomed during their one-week visit.
The Global OrthoBiologic Team successfully returned from their first medical training in the Balkans. Serbia was the first stop on the trip. The GOB team was represented by Dr. Himanshu Bansal, scientific advisory member, Mr. Randy Beimel, GOB President and Mr. Mihail Blagoev, VP International Business Development. Another scientific advisory member of our board – Dr. Dzihan Abazovic, invited the team to Belgrade.
The main reason for the Belgrade visit was the beginning of teamwork between Dr. Abazovic and Dr. Bansal. They both shared common health goals, physical and mental effort in assessing, planning, or evaluating patient care. Dr. Abazovic performed five spinal cord injuries procedures that day with the expert assistance of Dr. Bansal. The Serbian specialists were amazed and impressed by Dr. Bansal’s experience in Regenerative Medicine and he was invited to be a lecturer on the 3rd Symposium of Regenerative Orthopedics in Novi Sad (01-02 April, 2016).
Indian scientist Dr. Himanshu Bansal shared his extremely innovative project in front of his Serbian colleagues “Brain Death Reversal – First Ever Study in the World”. A team of doctors from India and the US, led by Dr. Bansal, is working on an ambitious project to infuse life into those deemed brain dead. As part of the project, the team has been granted ethical permission to recruit 20 patients declared clinically dead from traumatic brain injury. Global OrthoBiologic Inc is one of the proud sponsors of the project.
Dr. Stefano Batista was one of the doctors who also visited us during our stay in Serbia. He is well known for doing medical tourism to Africa from Europe and he was highly impressed by the Serbian facility of Dr. Abazovic. As soon as Dr. Batista found out that the facility is approved by the Serbian ministry of health to perform stem cell procedures, he immediately considered changing his African center for medical tourism to Belgrade.
Second stop of our medical training trip was Zagreb, Croatia. Dr. Abazovic presented his protocols and cases regarding wound care management in front of the members of company Stoma Medical. Željko Vuk and his colleagues were extremely impressed by the significant improvements of the patients just by using BMAC in the wound care management.
Our second meeting in Zagreb was with Dr. Mladen Miskulin. He specializes in orthopedics and traumatology and he is Assistant Professor at the University of Dubrovnik. We presented him the opportunity to use the Magellan® Autologous Platelet Separator in his sports medicine practice and the benefits he could receive from it.
The GOB team travelled on to Slovenia after the successful presentations in Croatia. Our partners from Educell were organizing their First Aesthetic Congress in Ljubljana and we were invited there in order to introduce the benefits of Magellan® Autologous Platelet Separator to the top aesthetics and dermatologists in the country. Dr. Abazovic was well received by the audience as he discussed the benefits of the highly concentrated product from a single therapy.
At the end of this medical training trip, the Global OrthoBiologic Team was invited to Serbia again for the 3rd Symposium of Regenerative Orthopedics in Novi Sad (01-02 April, 2016).
The Arab Health Exhibition & Congress is the largest healthcare exhibition & medical congress in the Middle East. The 2016 exhibition showcased more than 4,000 companies exhibiting their latest innovations to more than 130,000 healthcare professionals attending from 163 countries. We are happy to announce that we successfully presented all the companies and products from our portfolio and had huge success and much interest from doctors and distributors from around the world.
Here are some of our success stories and key achievement during Arab Health 2016:
GOB Team met with Mr. Essam Helmy, the master distributor of MicroPort in the Middle East. He is also distributing directly in Egypt and UAE. He was very interested in our company portfolio and he would like to include our products in his distribution network. He is considering joining us for the training in Kuwait and will introduce our product portfolio to his network. We also met with the owner of TRI ALPHA and he has a group of medical companies interested in our portfolio and he was extremely excited to meet with us during our upcoming trip in Kuwait next month.
Anton Atalla from Sigma Medical was very interested in reviewing our company presentation as he just started a medical distribution in Dubai and Jordan and he is searching for new products for his portfolio.
Company Modelex from Kuwait was very impressed with Frii Medical (Innovative Italian Company we represent in our portfolio) and they requested all the possible information regarding the FRII medical products.
Mohamed Darwish from Oman was very impressed with the PRP and BMAC devices which we mainly represent as the face of Arteriocyte.
Mr. Mahdi Madarshani from Iran went into straight discussion for partnership with Global OrthoBiologic with regards to importing products into the Iranian market. His main interest is in the Regenerative Medicine and the Rejuvenation field which we successfully represent.
GOB agreed to sign an agreement with Dr. Raafat from Abu Dhabi International Medical Services in order to support his company and introduce new products to the emirate market. Dr. Raafat has a significant interest in the wound management business and we were happy to share with him the Cytomedix wound care machine. GOB will give him the exclusive rights for the wound care market in UAE.
Kevin Zarrabi from Technoways was very impressed with some of the companies we represent – Reviscon and BioLife Scaffold. We agreed to begin the registration process in Dubai so we can schedule future trainings and sign exclusive agreements for spine and orthopedics.
Ali Al Bakri, the founder and owner of Al Bakri Oil and Pharma from Yemen made a proposal to GOB to represent our products on the Yemeni market.
Milan Shah from India is in the wound care sector. He wanted to discuss how our products could be directly applied. He made his first order during the exhibition – one centrifuge, 50 PRP kits, and 10 BioMac units. He will introduce us to a wound care company in Israel and a German distributor of spinal endoscopy products.
GOB was not only making new partnerships during the exhibition but we also were building stronger relationships with our current business partners who attended Arab Health. Mr. Fabio Barzghani from Frii Power who deals with orthoscopic surgical devices is one of our partners who we met there. We will help him introduce Frii Power to Lithuania, Jordan, India, and Kuwait and Mr. Barzghani will introduce us to his partners in Latin and South America.
VSY Biotechnology is one of the companies we are currently representing. Making a breakthrough, VSY Biotechnology entered into Orthopedics and PTR areas and launched the intra-articular injection brand Reviscon. During Arab Health GOB created a huge interest in Reviscon and we are ready to sign agreements with distributors from all over the world.
Nurel Medikal made a proposition to us to introduce their company to our international network. This is just one of the many companies that will be represented by Global OrthoBiologic following Arab Health. GOB will also begin to private label Israeli products in Europe.
By the last day of Arab Health, GOB has signed agreements with UAE, Iran, Jordan, Egypt, Oman, Yemen, Kuwait and Bahrain and we increased our portfolio with three new products.
Last but not least, GOB received an invitation by the president of the Arab Panam organization to lecture on regenerative medicine. This will take place in November of this year in Abu Dhabi or Morocco and we are sure that this exhibition will extend our product portfolio even more.
Global OrthoBiologic Inc.(GOB) together with its Turkish partner Global Biomedikal is pleased to announce the official launch of the Magellan BMAC kit in two of the largest cities in Turkey – Ankara and Istanbul. Medical trainings and meetings were organized in front of key doctors and university professors.
The first procedure was performed in Hacettepe University in Ankara by the head of the university, ProfessorMahmut NedimDoral, MD. GOB scientific officer Dr. Dzihan Abazovic assisted Prof. Doral’s team and Associate Professor, Dr. GaziHuri during the nonunion case. The team aspirated bone marrow from the patient’s tibia and processed itwiththe Magellan® Autologous Platelet Separator. After the procedure,the GOB team was invited to join Shoulder Club International(http://shoulderclub.com/). Thisisa great opportunity for Global OrthoBiologic Inc to become part of another international society and to confirm its importance in connecting the most innovative therapiesworldwide.
The official launch of the Magellan in Istanbul was held in the MedipolUniversity. This private university is highly respected in Turkey with the most innovative therapies launched in their Operating Rooms.Associate Prof. Ahmet Murat Bülbül MD is the head of the orthopedic team in Medipoland he alsomanages several OR simultaneously.GOB Team succeeded to impress him and captured all his attention with the easy noninvasive bone marrow aspiration draw from the tibia. He noted that the Magellan aspiration was easier, smoother and faster than the jamshidi version and he didn’t even had time to drink his cup of tea!
After the procedures, Global Biomedikal was invited by Medipol University to further explore ways to use the Magellan BMAC.
Dr.Bülbül and his team invited GOB to discuss a potential clinical study that would prove that the BMAC aspirated from the tibia outpatient using a local anesthetic will be a beneficial and more cost effective therapy for OA than available currently. This will give GOB the foundation to implement this therapy as an option to other procedures offered for OA.
Next stop on our Turkish visit was LIV Hospital for a meeting with GOB scientific board member Professor Erdal Karaoz.The main point of the discussion was the great opportunity to acquire the MBSI project in Switzerland with his active facility. During the meeting, our partners from Global Biomedikal received an invitation from the orthopedic department ofLiv Hospital to implement and promote the Magellan BMAC.
Finally, the GOB team visited our physician advisory board member Dr. Tahsin Beyzadeoglu. We discussed the opportunity for Global Biomedikal to start performing surgeries in the American Hospital in order to test the reimbursement process for the Magellan BMAC with the private insurances in Turkey. Dr. Beyzadeoglu agreed to assist Global Biomedikal to promote and implement our products in the American Hospital and Acibadem. He is willing to rent their OR in order to perform surgeries with the Magellan® Autologous Platelet Separator.
Dr. Abazovic discussed with Dr. Beyzadeoglu his innovative treatment for cartilage repair with fully autologous product. Dr. Beyzadeouglu accepted the invitation to participate in such a treatment next August in Belgrade.
About Global OrthoBiologic Inc.
Global OrthoBiologic Inc., based in Miami Florida, develops, markets, and globally distributes new and innovative products in the field of Regenerative Medicine. Global OrthoBiologic Inc. was established to promote and distribute groundbreaking medical technologies for use in therapies that significantly enhance the body’s natural healing ability. During the last decade, the company has developed extensive experience in the most advanced medical device industries and technologies. Global OrthoBiologic Inc. consults not only with startup biotech and medical technology companies, but also with mature companies that wish to better develop their international business. In the past several years, the company’s emphasis has been focused exclusively on Regenerative Medicine, such as stem cell technologies, products, and therapies. Global OrthoBiologic Inc. has built a comprehensive network of experts and country distributors in Europe, South America, Middle East, Asia, and Australia. Global OrthoBiologic Inc. has additional sales offices in Sofia, Bulgaria and Dubai, UAE, as well as a distribution center in Amsterdam, Netherlands.
About Global Biomedikal
Global Biomedical Product Portfolio
- Innovative Technologies
- Regenerative Therapies(Cell-Based)
- Treatments for chronic diseases